Back to Feed
ClinicalTrials.gov|Clinical Trial
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
USWM CT, LLC
Abstract
This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion. Phase: PHASE1 Status: RECRUITING Conditions: Neoplasms Interventions: ADP adoptive cell therapy
Keywords
Neoplasms